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A survey related to universal newborn hearing screening
was created with permission granted, based on the fol-
lowing study and adapted to the Italian situation: Primary
Care Physicians’ Knowledge, Attitudes, and Practices
Related to Newborn Hearing Screening (Mary Pat Moel-
ler, PhD, Karl R. White, PhD and Lenore Shisler, MS).
First distributed in October, 2008, the survey was given
to 300 pediatricians of Tuscany on a regional level, and
was then adapted as an online questionnaire made avail-
able to the members of the Italian Pediatric Federation
(FIMP) in April, 2009. The purpose of the survey was to
verify the attitudes, experience and knowledge of family
pediatricians, in regard to newborn hearing screening,
hearing loss and other related arguments.
The principle objectives of the study were (1) to pro-
vide an overview of the current situation of pediatricians
in regard to newborn hearing screening and follow-up;
(2) to evaluate the knowledge and experience of pediatri-
cians regarding newborn hearing screening programs and
(3) to identify the information gaps in order to evaluate
the most effective methods of providing the resources
and information necessary to assist the families whose
children are diagnosed with hearing loss.
The results indicated that there are knowledge gaps as to
how to properly manage cases of children with hearing
loss (for example, when and where to send newborns to
specialists for necessary follow-up care, genetics and deaf-
ness, the appropriate surveillance for late-onset congenital
hearing loss, as well as information on the cochlear
implant and the criteria for candidacy).
In the past five years, the FIMP Audiology Network has
performed Refresher courses on Newborn Hearing
Screening for over 5000 pediatricians. [1]
A principle concentration on Late Onset, Acquired
and Progressive Hearing Loss is now a fundamental
objective.
If Pediatricians do not intervene on a national level to
identify late onset hearing loss (congenital) and do not
perform that which is defined as “audiological surveil-
lance”, the screening thereby fails in its essence of being
“universal”. [2] In fact, the Newborn Hearing Screening
programs are not able to identify acquired or progressive
hearing loss that may occur after the first months or years
of life. The cases that represent an important percentage
(20-30% of all cases of infant hearing loss) may only be
identified through effective monitoring programs. [3]
Italian Pediatricians are in the position to guarantee
this level of surveillance.
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